#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cluster headache Deafness bilateral Angiosarcoma non-metastatic Lip and/or oral cavity cancer Juvenile idiopathic arthritis Non-small cell lung cancer Depression Small intestine adenocarcinoma Alveolar proteinosis Paraganglion neoplasm Haemophilia B with anti factor IX Obliterative bronchiolitis Thrombocytosis Obesity Indolent systemic mastocytosis More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma – Trials in Disease Urea cycle disorder – Basic Information Mantle cell lymphoma refractory – Treatment Acute respiratory distress syndrome – Treatment Haemophilia Turner’s syndrome Choroid melanoma – Life with Disease Mantle cell lymphoma stage II – Life with Disease Choroid melanoma Nodal marginal zone B-cell lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GUAIACOL Arbaclofen Lifileucel Crizotinib Cimetidine ULEFNERSEN Vidofludimus Calcium Budesonide Etuvetidigene Autotemcel Pramipexole Glucose Monohydrate Gad20-209-Fsp-A2 Air, Medicinal Tuvusertib AZD1163 Xenon (129Xe) Tipiracil Ceftriaxone Sodium Ribitol Promazine Hydrochloride More therapies…

    Learn about Your Condition

    Metabolic surgery Acarodermatitis Acute on chronic liver failure Impaired gastric emptying Colon cancer stage III Stem cell transplant Hypertriglyceridaemia Bronchiolitis Complicated appendicitis Frostbite Peyronie's disease Tetanus Anal squamous cell carcinoma Obsessive-compulsive disorder Gingival bleeding More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • High-grade B-cell lymphoma
    • Follicular lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Loncastuximab Tesirine
    Germany

  • Study on the Effects of INT230-6, Vinblastine Sulfate, and Cisplatin in Patients with Early Triple-Negative Breast Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Cisplatin
    • Vinblastine Sulfate
    France

  • Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    France Germany Italy Spain

  • Study on Improving Burn Scars with Adipose-Derived Stem Cells and Autologous Stromal Vascular Fraction for Patients with Hypertrophic Scarring

    Not yet recruiting

    1 1
    Investigated Diseases:
    • Hypertrophic scar
    Investigated Drugs:
    • Adrc001
    Denmark

  • Study on Colchicine and Tiemonium Methylsulphate for Reducing Atherosclerosis in Cancer Patients Undergoing Immune Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Tiemonium Methylsulphate
    • Colchicine
    The Netherlands

  • Study on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Relugolix
    Italy
Previous Page
1 … 813 814 815 816 817 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!